Skip to main content
. Author manuscript; available in PMC: 2025 Jul 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2024 Jul 1;96(3):259–269. doi: 10.1097/QAI.0000000000003440

Table 5:

Male Participant Outcomes including Female Characteristics in the Model

Variable Level Estimate 95% CI P-value
Study group Intervention 0.0927 (0.022, 0.1635) 0.0102
Age at enrollment (years) 0.0024 (−0.0007, 0.0055) 0.1296
Education None −0.0316 (−0.1087, 0.0455) 0.4216
Some-completed primary −0.0157 (−0.0571, 0.0257) 0.4577
Marital status Single 0.1002 (−0.106, 0.3064) 0.3407
Common law/live together −0.0873 (−0.3775, 0.2029) 0.5554
ART Regimen (enrollment) DTG 0.0686 (−0.013, 0.1501) 0.0993
Employment status Agriculture/Domestic 0.0069 (−0.0326, 0.0464) 0.7332
Depression score −0.0009 (−0.0066, 0.0048) 0.7623
HIV score (knowledge) 0.0037 (−0.0017, 0.0092) 0.1784
HIV score (stigma) 0.0010 (−0.0009, 0.003) 0.2981
Age at enrollment (years), female 0.0038 (−0.0003, 0.008) 0.0679
Education, female None −0.0121 (−0.0851, 0.061) 0.7462
Some-completed primary 0.0075 (−0.0521, 0.0672) 0.8043
Marital status, female Single −0.0905 (−0.2976, 0.1166) 0.3916
Common law/live together 0.1682 (−0.1223, 0.4587) 0.2563
ART Regimen (enrollment), female DTG 0.1323 (0.0494, 0.2151) 0.0018
Depression score, female −0.0010 (−0.0061, 0.0042) 0.7141
HIV score (knowledge), female 0.0035 (−0.0018, 0.0088) 0.1976
HIV score (stigma), female −0.0008 (−0.0028, 0.0012) 0.4340

Reference levels: Study group (control); Education (some secondary or beyond); Marital status (married); ART regimen (other); Employment status (other).

ART = Antiretroviral therapy; DTG = Dolutegravir.